Oct 25 (Reuters) - Neogenomics Inc :NeoGenomics reports revenue of $63.1 million on 17 percent volume growth and 11 percent reduction in average cost per test in the third quarter of 2017.Q3 adjusted earnings per share $0.01.Q3 revenue $63.1 million versus I/B/E/S view $63.5 million.Q3 earnings per share view $0.02 -- Thomson Reuters I/B/E/S.Sees Q4 loss per share $0.03 to $0.04.Sees Q4 revenue $65 million to $67 million.Q3 GAAP loss per share $0.10.Q4 earnings per share view $0.04, revenue view $66.8 million -- Thomson Reuters I/B/E/S.NeoGenomics Inc - expects Q4 adjusted diluted EPS to be $0.04 - $0.05 per share.
Full Article
Oct 12 (Reuters) - NeoGenomics Inc :NeoGenomics announces preliminary quarter 3 results, financial impacts of hurricanes and summary quarter 4 guidance.NeoGenomics Inc - it expects to report quarter 3 revenue of approximately $63.1 million and adjusted EBITDA of approximately $6.0 million.NeoGenomics Inc - NeoGenomics estimates that hurricanes Harvey and Irma depressed revenue by approximately $1.0 million in quarter 3.NeoGenomics inc - in addition, as a result of divestiture of pathlogic, Q3 revenue will be approximately $1.3 million less than in quarter 2.NeoGenomics Inc - expects consolidated revenue of $65 million - $67 million and adjusted EBITDA of $9 million -10 million in Q4.NeoGenomics-For Q3,expects to record $1.3 million revenue adjustment to reflect change in process for estimating revenue for unbilled tests at quarter-end.Q3 revenue view $65.9 million -- Thomson Reuters I/B/E/S.Q4 revenue view $69.1 million -- Thomson Reuters I/B/E/S.
Full Article
Neogenomics Inc : Neogenomics reports 159% revenue growth to $63.1 million and strong gains in profitability in the second quarter of 2016 . Q2 adjusted earnings per share $0.04 . Q2 loss per share $0.07 . Q2 revenue $63.1 million versus i/b/e/s view $61.1 million . Q2 earnings per share view $0.03 -- Thomson Reuters I/B/E/S .Neogenomics inc says reiterated guidance for fiscal year 2016.
Full Article
Neogenomics Inc :Files for stock shelf of up to $200 million - SEC filing.
Full Article
Earnings vs. 
Estimates